Solexa, Inc. To Participate In Cancer Genome Project Panel Discussion At 2005 Biotechnology Industry Organization (BIO) InvestorForum

HAYWARD, Calif. & CAMBRIDGE, UK--(BUSINESS WIRE)--Oct. 20, 2005--Solexa, Inc. (Nasdaq:SLXA) today announced that John West, chief executive officer of Solexa, will participate in panel presentation at the 2005 BIO InvestorForum today, Thursday, October 20, 2005 at 6:30 p.m. Eastern Time (3:30 p.m. Pacific Time). The presentation, entitled "Cancer Genome Project, Part I: Implications for Sequencing Technology," will discuss the Human Cancer Genome Project and its implications for technology and therapeutic industry participants.